Table 1.
Participant characteristics and comparisons between insured English-speaking (INS-English), un- and under-insured English-speaking, and un- and under-insured low English proficiency Hispanic individuals with cancer.
| Patient characteristics | INS-English | UN-English | UN-Spanish | p-value |
|---|---|---|---|---|
| (n of 31, %) | (n of 23, %) | (n of 23, %) | ||
| Age, Mean, standard deviation (SD) | 55.6, 14.0 | 44.1, 13.4 | 49.1, 13.8 | 0.023 |
| Gender % (n) | 0.37 | |||
| Male | 9 (29.0%) | 11 (47.8%) | 7 (30.4%) | |
| Female | 22 (71.0%) | 12 (52.2%) | 16 (69.6%) | |
| Neighborhood Area Deprivation Index Score, Mean, SD | 54.9, 25.8 | 65.0, 23.8 | 75.1, 16.6 | 0.03 |
| Currently Working for Pay | 0.001 | |||
| Yes | 15 (48.39%) | 3 (13.04%) | 2 (8.70%) | |
| No | 15 (48.39%) | 20 (86.96%) | 21 (91.30%) | |
| Income | <0.001 | |||
| <$10,000 | 2 (6.45%) | 10 (43.48%) | 6 (26.09%) | |
| $10,000–$34,999 | 4 (12.90%) | 12 (52.17%) | 6 (26.09%) | |
| $35,000–$49,999 | 3 (9.68%) | 1 (4.35%) | 0 (0%) | |
| $50,000–$99,999 | 13 (41.94%) | 0 (0%) | 0 (0%) | |
| >$100,000 | 8 (25.81%) | 0 (0%) | 0 (0%) | |
| No Response | 1 (3.3%) | 0 (0%) | 11 (47.8%) | |
| Education | <0.001 | |||
| Less than High School, High School, or GED | 10 (32.26%) | 15 (65.22%) | 14 (60.87%) | |
| Some College, Associate Degree, or Trade Certification | 14 (45.16%) | 8 (34.78%) | 0 (0%) | |
| College, Graduate, or Advanced Degree | 7 (22.58%) | 0 (0%) | 1 (4.35%) | |
| No Response | 0 (0%) | 0 (0%) | 8 (34.78%) | |
| Marital Status | 0.41 | |||
| Married or Living as Married | 18 (58.06%) | 9 (39.13%) | 11 (47.83%) | |
| Other | 13 (41.94%) | 14 (60.87%) | 12 (52.17%) | |
| Insurance | <0.001 | |||
| Private (Employer or Purchased) | 28 (90.32%) | 1 (4.35%) | 0 (0%) | |
| Medicaid or Other State | 0 (0%) | 6 (26.09%) | 2 (8.70%) | |
| Medicare | 3 (9.68%) | 1 (4.35%) | 1 (4.35%) | |
| No Insurance | 0 (0%) | 15 (65.22%) | 20 (86.96%) | |
| Received Chemotherapy | 0.10 | |||
| Yes | 23 (74.2%) | 20 (87.0%) | 22 (95.7%) | |
| No | 8 (25.8%) | 3 (13.0%) | 1 (4.4%) | |
| Advanced or Metastatic Cancer | 0.001 | |||
| Yes | 16 (51.6%) | 14 (60.9%) | 22 (95.7%) | |
| No | 15 (48.4%) | 9 (39.1%) | 1 (4.4%) | |
| Disease Site | ||||
| Breast | 16 (51.6%) | 8 (34.8%) | 6 (26.1%) | 0.34 |
| Gastrointestinal | 4 (12.9%) | 5 (21.7%) | 7 (30.4%) | |
| Other* | 11 (35.5%) | 10 (43.5%) | 10 (43.5%) | |
| Median Interval from Diagnosis in days (interquartile range) | 297 (82, 575) | 270 (99, 546) | 860 (173, 1,687) | 0.006 |
*Other disease sites include: central nervous system, head and neck, hematologic (leukemia, lymphoma, myeloma), lung, genitourinary, gynecologic, sarcoma and other soft tissue, and thymic malignancies. Bold values indicate p < 0.05.